checkAd

     101  0 Kommentare Physitrack PLC – Interim Report: December 2020 – November 2021

    LONDON, UK / ACCESSWIRE / January 26, 2022 / Physitrack (STO:PTRK)Financial highlights for the fourth quarter and twelve month period ended 30 November 2021Fourth quarter 2020/21 (September 2021 - November 2021)Revenue of EUR 2.4m (1.0m) for the …

    LONDON, UK / ACCESSWIRE / January 26, 2022 / Physitrack (STO:PTRK)

    Financial highlights for the fourth quarter and twelve month period ended 30 November 2021

    Fourth quarter 2020/21 (September 2021 - November 2021)

    • Revenue of EUR 2.4m (1.0m) for the quarter ended 30 November 2021. An increase of EUR 1.4m or 165 per cent compared to the same period last year.
    • Proforma revenue growth of 47 per cent for the quarter ended 30 November 2021 compared to the same period last year.
    • This growth was achieved in all businesses:
      • 47 per cent revenue growth of the existing Physitrack business compared to the same period last year against a strong prior year comparator
      • 11 per cent revenue growth of the acquired Physiotools and Mobilus ("Physiotools") businesses on a proforma basis
      • 150 per cent revenue growth of the acquired Rehabplus business on a proforma basis;
      • 122 per cent revenue growth of the acquired Fysiotest business on a proforma basis;
    • 3 month adjusted EBITDA of EUR 0.8m (0.4m) increased by 106 per cent compared to the same period last year;
    • Adjusted EBITDA margins of 32 per cent, a decrease from 41 per cent compared to prior year due to lower margins of recently acquired companies;
    • Profit after tax of EUR 0.3m (0.1m) for the quarter.

    12 Month period ended 30 November 2021 (December 2020 - November 2021)

    • Revenue of EUR 7.7m (3.1m) for the year ended 30 November 2021. An increase of EUR 4.6m or 153 per cent against the same period last year;
    • Proforma[1] revenue growth of 36 per cent for the year ended 30 November 2021 against the same period last year. This growth was achieved in all businesses:
      • 46 per cent revenue growth of the existing Physitrack business compared to the same period last year
      • 11 per cent revenue growth of the acquired Physiotools and Mobilus ("Physiotools") businesses on a proforma basis
      • 75 per cent revenue growth of the acquired Rehabplus business on a proforma basis
      • 122 per cent revenue growth of the acquired Fysiotest business on a proforma basis;
    • 12 month adjusted EBITDA[2] of EUR 2.6m (1.6m), increased by 58 per cent compared to the same period last year;
    • Adjusted EBITDA margins[3] of 33 per cent, a decrease from 53 per cent compared to prior year due to previously communicated lower margins of recently acquired companies;
    • One-off IPO and M&A expenses were incurred of EUR 1.6m, resulting in a loss after tax of EUR 0.6m (0.6m profit) for the 12 months.

    Henrik Molin, Co-founder and CEO of Physitrack PLC commented:

    Seite 1 von 3


    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    Physitrack PLC – Interim Report: December 2020 – November 2021 LONDON, UK / ACCESSWIRE / January 26, 2022 / Physitrack (STO:PTRK)Financial highlights for the fourth quarter and twelve month period ended 30 November 2021Fourth quarter 2020/21 (September 2021 - November 2021)Revenue of EUR 2.4m (1.0m) for the …